Sonoma Pharmaceuticals SNOA 深 沪
等待开盘 07-18 09:30:00 美东时间
3.58
-0.040
-1.10%
华盛通- 最 高3.75
- 今 开3.62
- 成交量 4.50万股
- 最 低 3.57
- 昨 收 3.62
- 总市值 588.12万
- 52周最高 8.624
- 市盈率 静 --
- 换手率 2.74%
- 52周最低 1.75
- 委 比 -98.76%
- 总股本 164.28万
- 历史最高 1484.64
- 量 比 0.16
- 振 幅 4.97%
- 历史最低 1.75
- 每 手 1
- 风险率 1.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sonoma Pharmaceuticals Q4 EPS $(0.48) Beats $(0.73) Estimate, Sales $3.75M Miss $4.44M Estimate
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.73) by 34.25 percent. This is a 65.47 percent increase over losses of $(1.39) per share
06-18 04:12
What's Going On With Sonoma Pharmaceuticals Stock Tuesday?
Sonoma stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products.
03-11 23:16
Market-Moving News for March 11th
LFMD: 33% | LifeMD shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 and FY25 revenue guidance above estimates. KSS: -18% | Kohl's shares are
03-11 19:19
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Paymentus Holdings, Inc. (NYSE:PAY) rose sharply in today's pre-marke...
03-11 18:55
3 Penny Stocks to Watch Now, 11/3/25
Sharps Technology, Checkpoint Therapeutics, and Sonoma Pharmaceuticals are the ...
03-11 17:52
Canopy Growth Corporation盘中异动 下午盘股价大跌5.24%
北京时间2025年02月01日02时59分，Canopy Growth Corporation（CGC.us）股票出现波动，股价快速下挫5.24%。截至发稿，该...
02-01 02:59
快讯 | 索诺玛制药公司 - 将在美国恢复销售Acuicyn, Celacyn, Epicyn, Lasercyn, Levicyn。
Sonoma Pharmaceuticals Inc - to Resume Selling Acuicyn, Celacyn, Epicyn, Laserc...
2024-11-22 05:41
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) stock moved upwards by 26.4% to $...
2024-11-20 05:06
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance For Microcyn-Based Wound Care Hydrogel
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications,
2024-11-19 21:49
Sonoma Pharmaceuticals Q2 2025 GAAP EPS $(0.59) Beats $(1.00) Estimate, Sales $3.60M Miss $3.98M Estimate
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(1.00) by 41 percent. The company reported quarterly sales of $3.60 million which missed
2024-11-07 21:50
